English
简体中文
Total: £ 56.28
Published Date: 2024-04-03 | Pages: 66 | Tables: 107 | New Technology
The global siRNA Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for siRNA Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding siRNA Drugs.
Report Scope
The siRNA Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global siRNA Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the siRNA Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam
Novartis
Sirnaomics
Ribo Life Science
Segment by Type
Without GalNAc-conjugated
With GalNAc-conjugated
Segment by Application
Genetic Disease
Cancers
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of siRNA Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global siRNA Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Without GalNAc-conjugated
1.2.3 With GalNAc-conjugated
1.3 Market by Application
1.3.1 Global siRNA Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Genetic Disease
1.3.3 Cancers
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global siRNA Drugs Market Perspective (2019-2030)
2.2 siRNA Drugs Growth Trends by Region
2.2.1 Global siRNA Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 siRNA Drugs Historic Market Size by Region (2019-2024)
2.2.3 siRNA Drugs Forecasted Market Size by Region (2025-2030)
2.3 siRNA Drugs Market Dynamics
2.3.1 siRNA Drugs Industry Trends
2.3.2 siRNA Drugs Market Drivers
2.3.3 siRNA Drugs Market Challenges
2.3.4 siRNA Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top siRNA Drugs Players by Revenue
3.1.1 Global Top siRNA Drugs Players by Revenue (2019-2024)
3.1.2 Global siRNA Drugs Revenue Market Share by Players (2019-2024)
3.2 Global siRNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by siRNA Drugs Revenue
3.4 Global siRNA Drugs Market Concentration Ratio
3.4.1 Global siRNA Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by siRNA Drugs Revenue in 2023
3.5 siRNA Drugs Key Players Head office and Area Served
3.6 Key Players siRNA Drugs Product Solution and Service
3.7 Date of Enter into siRNA Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 siRNA Drugs Breakdown Data by Type
4.1 Global siRNA Drugs Historic Market Size by Type (2019-2024)
4.2 Global siRNA Drugs Forecasted Market Size by Type (2025-2030)
5 siRNA Drugs Breakdown Data by Application
5.1 Global siRNA Drugs Historic Market Size by Application (2019-2024)
5.2 Global siRNA Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America siRNA Drugs Market Size (2019-2030)
6.2 North America siRNA Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America siRNA Drugs Market Size by Country (2019-2024)
6.4 North America siRNA Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe siRNA Drugs Market Size (2019-2030)
7.2 Europe siRNA Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe siRNA Drugs Market Size by Country (2019-2024)
7.4 Europe siRNA Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific siRNA Drugs Market Size (2019-2030)
8.2 Asia-Pacific siRNA Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific siRNA Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific siRNA Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America siRNA Drugs Market Size (2019-2030)
9.2 Latin America siRNA Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America siRNA Drugs Market Size by Country (2019-2024)
9.4 Latin America siRNA Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa siRNA Drugs Market Size (2019-2030)
10.2 Middle East & Africa siRNA Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa siRNA Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa siRNA Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam
11.1.1 Alnylam Company Detail
11.1.2 Alnylam Business Overview
11.1.3 Alnylam siRNA Drugs Introduction
11.1.4 Alnylam Revenue in siRNA Drugs Business (2019-2024)
11.1.5 Alnylam Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis siRNA Drugs Introduction
11.2.4 Novartis Revenue in siRNA Drugs Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Sirnaomics
11.3.1 Sirnaomics Company Detail
11.3.2 Sirnaomics Business Overview
11.3.3 Sirnaomics siRNA Drugs Introduction
11.3.4 Sirnaomics Revenue in siRNA Drugs Business (2019-2024)
11.3.5 Sirnaomics Recent Development
11.4 Ribo Life Science
11.4.1 Ribo Life Science Company Detail
11.4.2 Ribo Life Science Business Overview
11.4.3 Ribo Life Science siRNA Drugs Introduction
11.4.4 Ribo Life Science Revenue in siRNA Drugs Business (2019-2024)
11.4.5 Ribo Life Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global siRNA Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Without GalNAc-conjugated
Table 3. Key Players of With GalNAc-conjugated
Table 4. Global siRNA Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global siRNA Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global siRNA Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global siRNA Drugs Market Share by Region (2019-2024)
Table 8. Global siRNA Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global siRNA Drugs Market Share by Region (2025-2030)
Table 10. siRNA Drugs Market Trends
Table 11. siRNA Drugs Market Drivers
Table 12. siRNA Drugs Market Challenges
Table 13. siRNA Drugs Market Restraints
Table 14. Global siRNA Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global siRNA Drugs Market Share by Players (2019-2024)
Table 16. Global Top siRNA Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2023)
Table 17. Ranking of Global Top siRNA Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by siRNA Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players siRNA Drugs Product Solution and Service
Table 21. Date of Enter into siRNA Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global siRNA Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global siRNA Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global siRNA Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global siRNA Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global siRNA Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global siRNA Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global siRNA Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global siRNA Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America siRNA Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America siRNA Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America siRNA Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe siRNA Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe siRNA Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe siRNA Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific siRNA Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific siRNA Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific siRNA Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America siRNA Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America siRNA Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America siRNA Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa siRNA Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa siRNA Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa siRNA Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Alnylam Company Detail
Table 47. Alnylam Business Overview
Table 48. Alnylam siRNA Drugs Product
Table 49. Alnylam Revenue in siRNA Drugs Business (2019-2024) & (US$ Million)
Table 50. Alnylam Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis siRNA Drugs Product
Table 54. Novartis Revenue in siRNA Drugs Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Sirnaomics Company Detail
Table 57. Sirnaomics Business Overview
Table 58. Sirnaomics siRNA Drugs Product
Table 59. Sirnaomics Revenue in siRNA Drugs Business (2019-2024) & (US$ Million)
Table 60. Sirnaomics Recent Development
Table 61. Ribo Life Science Company Detail
Table 62. Ribo Life Science Business Overview
Table 63. Ribo Life Science siRNA Drugs Product
Table 64. Ribo Life Science Revenue in siRNA Drugs Business (2019-2024) & (US$ Million)
Table 65. Ribo Life Science Recent Development
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. Global siRNA Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global siRNA Drugs Market Share by Type: 2023 VS 2030
Figure 3. Without GalNAc-conjugated Features
Figure 4. With GalNAc-conjugated Features
Figure 5. Global siRNA Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global siRNA Drugs Market Share by Application: 2023 VS 2030
Figure 7. Genetic Disease Case Studies
Figure 8. Cancers Case Studies
Figure 9. Other Case Studies
Figure 10. siRNA Drugs Report Years Considered
Figure 11. Global siRNA Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global siRNA Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global siRNA Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global siRNA Drugs Market Share by Players in 2023
Figure 15. Global Top siRNA Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in siRNA Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by siRNA Drugs Revenue in 2023
Figure 17. North America siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America siRNA Drugs Market Share by Country (2019-2030)
Figure 19. United States siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe siRNA Drugs Market Share by Country (2019-2030)
Figure 23. Germany siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific siRNA Drugs Market Share by Region (2019-2030)
Figure 31. China siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America siRNA Drugs Market Share by Country (2019-2030)
Figure 39. Mexico siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa siRNA Drugs Market Share by Country (2019-2030)
Figure 43. Turkey siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia siRNA Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Alnylam Revenue Growth Rate in siRNA Drugs Business (2019-2024)
Figure 46. Novartis Revenue Growth Rate in siRNA Drugs Business (2019-2024)
Figure 47. Sirnaomics Revenue Growth Rate in siRNA Drugs Business (2019-2024)
Figure 48. Ribo Life Science Revenue Growth Rate in siRNA Drugs Business (2019-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
